Development of an HSV-1 neutralization test with a glycoprotein D specific antibody for measurement of neutralizing antibody titer in human sera

about

Development of an HSV-1 neutralization test with a glycoprotein D specific antibody for measurement of neutralizing antibody titer in human sera

Item

http://www.wikidata.org/entity/Q36700993

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Development of an HSV-1 neutra ...... g antibody titer in human sera

@ast

Development of an HSV-1 neutra ...... g antibody titer in human sera

@en

type

Item

label

Development of an HSV-1 neutra ...... g antibody titer in human sera

@ast

Development of an HSV-1 neutra ...... g antibody titer in human sera

@en

prefLabel

Development of an HSV-1 neutra ...... g antibody titer in human sera

@ast

Development of an HSV-1 neutra ...... g antibody titer in human sera

@en

P1476

Development of an HSV-1 neutra ...... g antibody titer in human sera

@en

P2093

Chao-Long Lin

http://www.w3.org/2001/XMLSchema#string

Cheng-Hao Huang

http://www.w3.org/2001/XMLSchema#string

Dan Xiong

http://www.w3.org/2001/XMLSchema#string

Huan-Huan Li

http://www.w3.org/2001/XMLSchema#string

Jun Zhang

http://www.w3.org/2001/XMLSchema#string

Qin Chen

http://www.w3.org/2001/XMLSchema#string

Quan Yuan

http://www.w3.org/2001/XMLSchema#string

Sheng-Ping Qiu

http://www.w3.org/2001/XMLSchema#string

Yong Luo

http://www.w3.org/2001/XMLSchema#string

P2860

HSV-2: in pursuit of a vaccine

Phase I/II study of oncolytic herpes simplex virus NV1020 in patients with extensively pretreated refractory colorectal cancer metastatic to the liver

Plaque reduction neutralization test for human cytomegalovirus based upon enhanced uptake of neutral red by virus-infected cells

Oncolytic herpes simplex virus vectors for cancer virotherapy

Single-round HIV type 1 neutralization measured by ELISPOT technique in primary human cells.

A phase 1 trial of oncolytic HSV-1, G207, given in combination with radiation for recurrent GBM demonstrates safety and radiographic responses.

Enzyme-linked immunospot assay for detection of human respiratory syncytial virus f protein-specific gamma interferon-producing T cells.

Prospects for control of herpes simplex virus disease through immunization.

Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review.

Gene transfer with herpes simplex vectors.

P2888

s12985-016-0508-4

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12985-016-0508-4

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ningshao Xia

P577

2016-03-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

298908223

http://www.w3.org/2001/XMLSchema#string

P6179

1030569389

http://www.w3.org/2001/XMLSchema#string

P698

26987753

http://www.w3.org/2001/XMLSchema#string

P932

4797254

http://www.w3.org/2001/XMLSchema#string